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crucial, because without such support, any possible 
positive eﬀ ect associated with pharmacotherapy 
could be overwhelmed by personal and environmental 
challenges faced by many women. Finally, the issue 
of possible unintended consequences (positive or 
negative) of the provision of progesterone to post-
partum women needs further exploration, particularly 
with respect to changes in maternal behaviour and 
aggression.
Yonkers and colleagues suggest that future research 
should focus on possible mediators of the eﬀ ect of 
progesterone. However, the immediate need is to 
identify the moderators of treatment success. “It is 
much more important to know what sort of a patient 
has a disease than what sort of disease a patient has”, 
goes the quote oft attributed to William Osler from 
almost a century ago, emphasising the importance of 
knowing about patient characteristics. Gordon Paul,4 
in the context of psychotherapy research, argued that 
what was important to know was: “What treatment, 
by whom, is most eﬀ ective for this individual with 
that speciﬁ c problem, and under which set of 
circumstances?” These lessons remain important for 
patient care and research. Future research needs to 
determine for which patients, in what treatment 
settings (eg, inpatient, outpatient), and with what 
treatment model (eg, comprehensive treatment, 
behavioural treatment only) progesterone could 
be eﬀ ective. If such a population were identiﬁ ed, 
investigation of possible mediating factors could then 
be informative. 
Yonkers and colleagues’ ﬁ ndings suggest that pro-
gesterone might prevent relapse in post-partum 
women who are cocaine-abstinent and reduce use in 
those who have used cocaine infrequently since giving 
birth. The possibility that such a drug treatment, 
pending results of larger, adequately powered studies, 
might become available for providers to support 
women in their recovery eﬀ orts is exciting and has 
implications for helping to keep families together. The 
contexts in which it should be given, as well as the dose, 
duration, and eﬀ ects on maternal–child interactions, 
should be investigated in future studies.
No single study can answer all the questions that 
researchers and readers might want answered. Indeed, 
a well designed and well executed study might leave 
us with more questions, and no answers. However, if 
the questions that remain after a study allow future 
researchers to ask and answer better questions, then 
that study can be regarded as successful. By this 
yardstick, Yonkers and colleagues have moved research 
into the treatment of substance use forward—they are 
able to propose potentially important answers and to 
raise crucial questions. Their results provide promise 
for the treatment of post-partum women who use 
cocaine. 
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Improving outcomes in social anxiety disorder
Social anxiety disorder is increasingly recognised as a 
highly prevalent and debilitating disorder, with huge 
costs in terms of personal distress of patients and 
economic costs to society.1 A substantial number of 
randomised controlled trials have examined the eﬀ ects 
of treatments for social anxiety disorders, and although 
both psychological and pharmacological treatments are 
eﬀ ective, there is still a lot we do not know. 
The network meta-analysis of treatments for 
social anxiety disorders by Evan Mayo-Wilson and 
colleagues2 in The Lancet Psychiatry is an important 
next step in improving our knowledge about these 
treatments. With more than 100 trials and thousands 
of patients included, their study integrates the 
present knowledge of these treatments. The ﬁ ndings 
conﬁ rm that both psychological and pharmacological 
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treatments are eﬀ ective, and that the eﬀ ects of 
these treatments are large. The eﬀ ect sizes reported 
for individual cognitive–behavioural therapy (CBT 
standardised mean diﬀ erence –1·19, 95% credible 
interval –1·56 to –0·81) and selective serotonin-
reuptake inhibitors and serotonin–norepinephrine 
reuptake inhibitors (–0·91, –1·23 to –0·60) correspond 
to a number-needed-to-treat of less than two 
compared with waitlist.3 The message that social 
anxiety disorder can often be treated successfully is 
important from a public health perspective, and would 
certainly be a good subject for an educational public 
campaign. Many patients with social anxiety disorder 
struggle to accept that they have a mental health 
problem and need help. Making these people aware 
that eﬀ ective treatments exist is certainly important. 
How can treatments of social anxiety disorders 
be further improved? One important issue is the 
long-term eﬀ ects of treatment. In their meta-
analysis, Mayo-Wilson and colleagues2 consider CBT 
to be the best initial treatment option, because its 
eﬀ ects are well-maintained at follow-up, whereas 
selective serotonin-reuptake inhibitors and serotonin–
norepinephrine reuptake inhibitors are known to be 
associated with in high relapse rates.4,5 However, the 
long-term eﬀ ects of treatments could not be included 
in this meta-analysis because the number of studies 
examining this was too small. For approval of drugs, 
only short-term evidence is needed. However, to really 
help patients and reduce their distress, long-term trials 
on drugs and psychotherapy are urgently needed. 
Another issue that is important for further improve-
ment of treatments is research on combined 
treatments. Only ﬁ ve trials examining combined 
treatment could be included in the meta-analysis by 
Mayo-Wilson. Although the outcomes of these studies 
showed numerically higher eﬀ ect sizes for combined 
treatment versus their respetive monotherapies, the 
eﬀ ects were not signiﬁ cantly diﬀ erent; this ﬁ nding 
might well be a matter of statistical power. In the 
specialty of depression, the outcomes of combined 
treatment have long been thought to equal those 
of either treatment alone. But as the number of 
trials increased over time, the additional beneﬁ ts 
of combined treatment, albeit being small, became 
signiﬁ cant and clinically relevant.6,7 This ﬁ nding 
has also been shown for panic disorders; combined 
treatment is superior to either pharmacotherapy or 
psychotherapy alone.6,8 Moreover, combined treatment 
is signiﬁ cantly more eﬀ ective than pharmacotherapy 
alone in obsessive-compulsive disorder.6 More research 
comparing combined treat ments with either treatment 
alone in social anxiety disorders is therefore needed, 
but a ﬁ nding of even better eﬀ ect sizes for combined 
treatments than for monotherapies would not come as 
a surprise.
Another interesting ﬁ nding from the meta-analysis 
by Mayo-Wilson and colleagues2 is that psychological 
treatments can also be successfully applied as guided 
self-help or internet-based treatments. Although 
the eﬀ ect of guided self-help compared with waitlist 
(standardised mean diﬀ erence –0·86, 95% credible 
interval –1·36 to –0·36) was smaller than that of 
individual CBT (–1·19, –1·56 to –0·81), the diﬀ erence 
was not signiﬁ cant (–0·32,–0·94 to 0·30), and 
the eﬀ ects of guided self-help or internet-based 
treatments were large and signiﬁ cant. This ﬁ nding is 
in line with previous ﬁ ndings of the eﬀ ectiveness of 
internet-based self-help treatments for other mental 
disorders.9 The positive outcome of self-help might 
not improve the outcomes of treatments directly, but 
it certainly oﬀ ers new possibilities to deliver eﬀ ective 
treatments more easily to patients and to lower the 
threshold for seeking help. We think that individual 
CBT should remain the ﬁ rst-choice treatment, but 
patients with social anxiety disorders are reluctant 
to seek help from professionals. Therefore, patients 
might prefer to receive this help through a book or the 
internet, with only limited contact with a professional 
through email or telephone. This method might 
result in an increased number of patients receiving 
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evidence-based treatment, thus reducing the personal 
distress and societal costs of social anxiety disorders.
We conclude that the meta-analysis by Mayo-Wilson 
and colleagues2 showed that social anxiety disorders 
can be treated eﬀ ectively with psychological and 
pharmacological treatments. There are also several 
promising options to even further improve these 
outcomes. Good news for our patients!
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Mental health technologies and the needs of cultural groups
Behavioural intervention technologies use devices 
such as mobile phones, the internet, and sensors to 
aﬀ ect behaviours and cognitions related to health, 
mental health, and wellness. Behavioural intervention 
technologies can be used for patient self-help, to support 
lay providers, or to promote communication between 
providers and patients.1 With more than 6 billion mobile 
phone subscriptions worldwide, these technologies 
oﬀ er great promise. However, to be eﬀ ective, they must 
be designed to meet the needs of the diverse cultural 
groups that use them.2 Culture can be deﬁ ned as the 
thoughts, communications, actions, customs, beliefs, 
values, and institutions of racial, ethnic, religious, or 
social groups.3 Interventions that respond to a culture’s 
needs and capabilities, and that appropriately harness 
available technologies, are more likely to result in the 
intended goals than are those that do not.4
Culture can affect the way in which mental health 
problems are perceived and defined by the individual 
and community—eg, the extent to which mental 
health problems are perceived as somatic or emotional 
symptoms, or believed to be real or imagined.3 The 
level of stigmatisation of mental health problems 
varies widely across cultures. Culture also affects 
factors that might contribute to the design and use of 
behavioural intervention technologies. Symbols and 
colours can have different meanings across cultures 
and can suggest varying levels of risk or usability. 
For example, a shock symbol in the USA indicates 
danger to most, but it might have no meaning or 
indicate a winding road to people in Ghana or other 
countries.5 Such cultural factors, along with who the 
end-users are (patients, care providers, family, or 
community members) and what role they have in 
the intervention, should be considered in the design 
of a behavioural intervention technology, including 
how messaging is framed and how symbols and 
metaphors are used. 
Behavioural intervention technologies are delivered 
in different ways, because of different capacities 
of the technological environment and variations in 
use patterns. For example, members of low-income 
ethnic minority communities in the USA use mobile 
phones to access the internet more frequently than do 
low-income white people, partly because broadband 
access is lower in minority communities.6 Thus, 
mobile interventions could be more useful than web-
based interventions for these groups and populations. 
In some African countries, mobile phones are 
ubiquitous, but electricity and internet connectivity 
are not. Thus, applications for these communities 
should run natively on the phone or device, and not 
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